Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Saba Capital Management, L.P. CEV Eaton Vance California Municipal Income Trust 13D/A 13.68% 2y
PAR Investment Partners, L.P. GRPN Groupon, Inc. 13G/A 2.7% 2y
Volition Capital Fund IV, L.P. GROV Grove Collaborative Holdings, Inc. 13D/A 16.8% 2y
Magnetar Financial LLC CMTL Comtech Telecommunications Corp 13D/A 11.73% 2y
Robert W. Duggan PLSE Pulse Biosciences, Inc. 13D/A 68.8% 2y
Orin Hirschman INAB In8bio, Inc. 13G 9.4% 2y
NOVO HOLDINGS A/S LXEO Lexeo Therapeutics, Inc. 13G/A 4.9% 2y
L1 Capital Global Opportunities Master Fund, Ltd. PHUN Phunware, Inc. 13G 9.32% 2y
ARCH Venture Fund XII, L.P. NMRA Neumora Therapeutics, Inc. 13D/A 20.9% 2y
Equinox Partners Investment Management LLC GAU Galiano Gold Inc. 13G/A 15.8% 2y
Fourth Sail Capital LP ARCE Arco Platform Limited Class A Common Shares 13G/A 0% 2y
JUPITER ASSET MANAGEMENT LTD WU Western Union CO 13G 4.96% 2y
Aimei Investment Ltd AFJK Aimei Health Technology Co., Ltd. 13D 21.1% 2y
Atalaya Capital Management LP AAGR African Agriculture Holdings Inc. Common Stock 13G/A 9.69% 2y
Antofagasta plc BVN Buenaventura Mining Co Inc 13D 18.9% 2y
Amster Howard WHLR Wheeler Real Estate Investment Trust, Inc. 13D 7.87% 2y
Li Kin Shing FEBO Fenbo Holdings Ltd 13D 72.73% 2y
Genextra S.p.A. IRLA IRulya Therapeutics Inc. 13G 5.89% 2y
Ganz Bryan BYRN Byrna Technologies Inc. 13D 7.7% 2y
Caligan Partners LP LQDA Liquidia Corp 13D/A 15.1% 2y
Centerbridge Credit Partners Master, L.P. GTX Garrett Motion Inc. 13D/A 16.42% 2y
Saba Capital Management, L.P. NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND 13D/A 13.4% 2y
Athanor Capital, LP ZURA Zura Bio Ltd 13G 11.01% 2y
MMCAP International Inc. SPC WSTRF Western Uranium & Vanadium Corp. 13G 9.99% 2y
L. John Doerr AMRS Amyris Inc. 13D/A 31.2% 2y
Saba Capital Management, L.P. SABA Saba Capital Income & Opportunities Fund II 13D/A 17.28% 2y
James N. Topper KALV KalVista Pharmaceuticals, Inc. 13D/A 10.4% 2y
Walmart Inc. SYM Symbotic Inc. 13D/A 52.6% 2y
Abdiel Qualified Master Fund, LP APPN Appian Corp 13D/A 15.8% 2y
MAK CAPITAL ONE LLC AGYS Agilysys Inc 13D/A 14% 2y
Cowen Financial Products LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G 10.1% 2y
Cormorant Asset Management, LP EYPT EyePoint, Inc. 13G/A 12.36% 2y
George Economou SHIP Seanergy Maritime Holdings Corp. 13D/A 7.2% 2y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D/A 13.7% 2y
Robert Davidow ATXI Avenue Therapeutics, Inc. 13G/A 9.89% 2y
Engine Capital, L.P. OFIX Orthofix Medical Inc. 13D/A 8.3% 2y
ORBIMED ADVISORS LLC KROS Keros Therapeutics, Inc. 13D/A 4.2% 2y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 14.63% 2y
Firment Shipping Inc. GLBS Globus Maritime Ltd 13D/A 20.5% 2y
Karpus Management, Inc. WIA Western Asset Inflation-Linked Income Fund 13D 30.47% 2y
Silver Point Capital L.P. GPOR Gulfport Energy Corp 13D/A 36.9% 2y
Saba Capital Management, L.P. BCAT BlackRock Capital Allocation Term Trust 13D/A 12.42% 2y
Ara K. Hovnanian HOV Hovnanian Enterprises Inc 13D/A 15.1% 2y
RA CAPITAL MANAGEMENT, L.P. ETNB 89bio, Inc. Common Stock 13D/A 13.6% 2y
Engaged Capital LLC UPBD Upbound Group, Inc. 13D/A 4.7% 2y
BAKER BROS. ADVISORS LP PRLD Prelude Therapeutics Inc 13D/A 24.3% 2y
Western Standard LLC MACK Merrimack Pharmaceuticals, Inc. 13D/A 15.5% 2y
Keenan Capital, LLC ARCE Arco Platform Limited Class A Common Shares 13D/A 0% 2y
GARDNER LEWIS ASSET MANAGEMENT L P BSQR BSQUARE Corporation 13D/A 0% 2y
Fred B. Craves MDGL Madrigal Pharmaceuticals, Inc. 13D/A 2.9% 2y